Toward a transgenic mouse model of remyelination

Multiple Sclerosis

Volumn 3, Issue 2, 1997, Pages 80-83

  Ferraresi, S ^a   Lorenzetti, I ^a   Nemni, R ^a   Kamholz, J ^b   Feltri, M L ^a   Wrabetz, L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibroblast growth factor; Myelin basic protein promoter; Oligodendrocytes; Platelet derived growth factor; Remyelination; galactosidase

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GALACTOSYLCERAMIDE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; MOUSE; NONHUMAN; OLIGODENDROGLIA; REMYELINIZATION; TRANSGENIC MOUSE;

EID: 0030804213     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300204     Document Type: Conference Paper

References (21)

1. Barres BA, Hart IK, Coles HS et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46.
2. Eckenstein FP, Shipley GD, Nishi R. (1991) Acidic and basic fibroblast growth factors in the nervous system: distribution and differential alteration of levels after injury of central versus peripheral nerve. J Neurosci 11: 412-419.
3. Feltri M et al. (1992) Mitogen-expanded Schwann cells retain the capacity to myelinate regenerating axons following transplantation into rat sciatic nerve. Proc Nat Acad Sci 89: 8827-8831.
4. Friedrich Jr VL, Lazzarini RA. (1993) Restricted migration of transplanted oligodendrocytes or their progenitors, revealed by transgenic marker M beta P. J Neural Transplant Plast 4: 139-146.
5. Gogate N, Verma L, Zhou JM et al. (1994) Plasticity in the adult human oligodendrocyte lineage. J Neurosci 14: 4571-4587.
6. Goujet-Zalc C, Babinet C, Monge M et al. (1993) The proximal region of the MBP gene promoter is sufficient to induce oligodendroglial-specific expression in transgenic mice. Eur J Neurosci 5: 624-632.
7. Grinspan J, Wrabetz L, Kamholz J. (1993) Oligodendrocyte maturation and myclin gene expression in PDGF-treated cultures from rat cerebral white matter. J Neurocytol 22: 322-333.
8. Grinspan JB et al. (1994) Protein growth factors as potential therapies for central nervous system demyelinative disorders. Ann Neurol 36: S140-142.
9. Grinspan JB, Stern JL, Franceschini B, Pleasure D. (1993) Trophic effects of basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: a mechanism for regeneration of the oligodondroglial lineage. J Neurosci Res 36: 672-680.
10. Grinspan JB, Stern JL, Pustilnik SM, Pleasure D. (1990) Cerebral white matter contains PDGF-responsive precursors to O2A cells. J Neurosci 10: 1866-1873.
11. Hardy RJ, Friedrich VL. (1996) Oligodendrocyte progenitors are generated throughout the embryonic mouse brain, but differentiate in restricted foci. Development 122: 2059-2069.
12. Lachapelle F et al. (1994) Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur J Neurosci 6: 814-824.
13. Louis J et al. (1992) CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31: 193-204.
14. Lubetzki C, Demerens C, Goujet-Zalc C et al. (1993) Axonal contact induces the final maturation step of oligodendrocytes leading to myelination. Abst Int Soc Neurochem Satellite Mtg on Myelin 27: (Abstract).
15. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603-614.
16. Molineaux SM, Engh H de FF, Hudson L, Lazzarini RA. (1986) Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation. Proc Natl Acad Sci USA 83: 7542-7546.
17. Prayoonwiwat N, Rodriguez M. (1993) The potential for oligodendroglial proliferation during demyelinating disease. J Neuropathol Exp Neurol 52: 55-63.
18. Raine CS. (1994) The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 30: S61-72.
19. Ranscht B et al. (1982) Development of oligodendrocytes and schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 79: 2709-2713.
20. Shirazi Y, Rus HG, Macklin WB, Shin ML. (1993) Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol 150: 4581-4590.
21. Wrabetz L et al. (1994) A human MBP promoter-lacZ transgene is expressed in an oligodendrocyte-specific and developmentally-regulated pattern in mice. Soc Neurosci Abst 20: 886 (Abstract).